Background: Ras guanine nucleotide-releasing protein 2 (RASGRP2), one of the guanine nucleotide exchange factors (GEFs), has attracted much attention in recent years. However, the correlation between RASGRP2 and immune infiltration and malignant features in lung adenocarcinoma (LUAD) has rarely been mentioned.
Methods: The Limma package and the LASSO regression model were performed to screen for differentially expressed genes. Data from the TCGA and 5 GEO databases were used to explore the expression level of RASGRP2 in LUAD patients. A weighted co-expression network and LinkFinder module were established to find the related genes of RASGRP2. The ESTIMATE algorithm was used to analyze the correlation between RASGRP2 and immune infiltration in LUAD. Tumor-infiltrating immune cells were sorted and sequenced at the single-cell level to analyze differences in RASGRP2. Real-time PCR and immunohistochemistry were performed in the real-world cohort to verify the expression of RASGRP2 and its correlation with immune-related genes. Clone formation and EdU assays were used to verify the proliferation ability. The proportion of apoptotic cells was analyzed by flow cytometry. Observation of mitochondrial membrane potential (MMP) changes by fluorescence microscopy.
Results: Our results suggested that decreased RASGRP2 was associated with worse clinical parameters and prognosis in LUAD patients. And we constructed a FLI1-HSA-miR-1976-RASGRP2 transcriptional network to support the role of RASGRP2. Enrichment analysis revealed that RASGRP2 was involved in lymphocyte activation and leukocyte adhesion. RASGRP2 was found to be positively correlated with the infiltration of most immune cells, immunoregulators, and chemokines in a subsequent study. Meanwhile, the real-world cohort confirmed that the expression levels of PDCD1, CTLA4, CD40LG, CCL14, CXCR5, and CCR7 were higher in the high-RASGRP2 expression group. Cytological experiments proved that RASGRP2 inhibited cell proliferation in LUAD by regulating mitochondrial-dependent apoptosis.
Conclusion: RASGRP2 was a potential immune-related biomarker of LUAD. In addition, RASGRP2 was involved in the malignant progression of LUAD through the regulation of mitochondrial-dependent apoptosis.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936229 | PMC |
| http://dx.doi.org/10.3389/fimmu.2023.1100231 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A splice mutation in gene in the patient with recurrent epistaxis and nasal vascular malformation.
Platelets
December 2024
Department of Hematology, Kunming Children's Hospital, Kunming, China.
Platelet type bleeding disorder-18 (BDPLT18) caused by mutations of Ras guanyl releasing protein 2 () is a relatively rare, new autosomal recessive disorder. Here, we reported a splice mutation in gene in the patient with recurrent epistaxis and nasal vascular malformation. The patient, an 8-year-old girl, suffered from anemia due to frequently severe recurrent epistaxis, requiring regular blood transfusions every 2-3 months.
View Article and Find Full Text PDFLoss of CCL28 and CXCL17 Expression and Increase in CCR1 Expression May Be Related to Malignant Transformation of LGBLEL into Lymphoma.
Curr Issues Mol Biol
September 2024
Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.
To investigate the differential expression of the chemokine signaling pathway in lacrimal gland benign lymphoepithelial lesion (LGBLEL) and lacrimal lymphoma, providing insights into the mechanisms underlying malignant transformation and aiding clinical differentiation. Transcriptome analysis was conducted on patients with LGBLEL, lymphoma, and orbital cavernous hemangioma (CH). Three cases of LGBLEL and three cases of lymphoma were randomly selected as control and experimental groups, respectively.
View Article and Find Full Text PDFNEDD4L-mediated RASGRP2 suppresses high-glucose and oxLDL-induced vascular endothelial cell dysfunctions by activating Rap1 and R-Ras.
Biochim Biophys Acta Mol Cell Res
December 2024
The Second Affiliated Hospital of Chongqing Medical University Cardiology Department, Chongqing, China. Electronic address:
Article Synopsis
- RASGRP2 is a crucial regulator of endothelial cell function, and its role in the progression of diabetes-related atherosclerosis is being explored for the first time.
- In experiments, low levels of RASGRP2 in endothelial cells exposed to high glucose and oxidized low-density lipoprotein were linked to increased cell permeability, apoptosis, and oxidative stress, while RASGRP2 overexpression showed protective effects.
- The study suggests that targeting the interaction between RASGRP2 and NEDD4L, or using modified exosomes from stem cells that overexpress RASGRP2, could provide effective strategies for addressing endothelial dysfunction in diabetic conditions.
Association between MAPK and PI3K/Akt signaling pathway-related gene polymorphisms and migraine.
Mol Genet Genomic Med
August 2024
Department of Epidemiology, School of Public Health, Harbin Medical University, Harbin, China.
Background: The causes of migraine remain unclear. Evidence suggests that the MAPK and PI3K/Akt signaling pathways play a role in migraine pathogenesis. However, studies on genetic polymorphisms in the two pathways associated with migraine are still limited.
View Article and Find Full Text PDFUtility of thromboelastography with platelet mapping for monitoring platelet transfusion in qualitative platelet disorders.
J Thromb Haemost
October 2024
Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill, North Carolina, USA; Blood Research Center, University of North Carolina, Chapel Hill, North Carolina, USA. Electronic address:
Background: Patients with pathogenic variants in RASGRP2 (inherited platelet disorder (IPD)-18) exhibit normal platelet counts but impaired platelet aggregation and αβ activation. Moderate-to-severe bleeding episodes require patients to be transfused with platelets and/or pro-hemostatic agents. We recently demonstrated that hemostatic efficacy of transfused platelets is limited by dysfunctional endogenous platelets in a mouse model of IPD-18 (Rasgrp2 mice), as dysfunctional platelets were recruited to the forming hemostatic plug but did not participate in clot contraction.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!